Related Experiment Video

Updated: Jun 21, 2026

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

p30 DBC is a potential regulator of tumorigenesis

Ja-Eun Kim1, Junjie Chen, Zhenkun Lou

  • 1Department of Pharmacology, Kyung Hee University School of Medicine, Seoul, Korea. jekim@khu.ac.kr

Cell Cycle (Georgetown, Tex.)
|August 7, 2009
PubMed

Insights

Deleted in Breast Cancer 1 (DBC1) protein has dual roles in tumorigenesis, acting as both an oncogene and tumor suppressor. Its function as a SIRT1 inhibitor is key to understanding its complex involvement in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumorigenesis involves complex protein functions, traditionally categorized as oncogenes or tumor suppressors.
  • Some proteins exhibit dual roles, acting as both oncogenes and tumor suppressors.
  • p30 DBC (deleted in breast cancer 1) is a protein with a complex role in tumorigenesis.

Purpose of the Study:

  • To review current understanding of p30 DBC functions in tumorigenesis.
  • To focus on the proposed roles of p30 DBC in cancer development.
  • To explore the dual oncogenic and tumor-suppressive activities of p30 DBC.

Main Methods:

  • Literature review of studies on p30 DBC.
  • Analysis of p30 DBC's involvement in cell proliferation, apoptosis, and histone modification.
  • Examination of p30 DBC's inhibitory effect on SIRT1 deacetylase.

Main Results:

  • p30 DBC participates in cell proliferation, apoptosis, and histone modification.
  • Conflicting results exist regarding p30 DBC's precise contribution to tumorigenesis.
  • p30 DBC is a potent inhibitor of SIRT1, a protein whose role in tumorigenesis is debated.

Conclusions:

  • p30 DBC presents a complex profile, not fitting traditional oncogene or tumor suppressor classifications.
  • Understanding p30 DBC's interaction with SIRT1 is crucial for elucidating its role in tumorigenesis.
  • Further research is needed to fully clarify the multifaceted roles of p30 DBC in cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...